Aenitis annonce un financement stratégique pour redéfinir les standards de la bioproduction grâce à sa technologie unique d’acoustofluidique
10 oct. 2024 02h00 HE
|
Aenitis Technologies
Aenitis annonce un financement stratégique pour redéfinir les standards de la bioproduction grâce à sa technologie unique d’acoustofluidique Aenitis est en passe de transformer la...
Aenitis Secures Strategic Funding to Redefine Bioproduction with Sole-In-Class Acoustofluidic Technology
10 oct. 2024 02h00 HE
|
Aenitis Technologies
Aenitis Secures Strategic Funding to Redefine Bioproduction with Sole-In-Class Acoustofluidic Technology Aenitis is set to transform the bioproduction industry by addressing the increasing...
eureKING, premier SPAC européen de la santé dédié à la bioproduction, annonce la signature d'une option de vente pour l’acquisition potentielle de Skyepharma pour créer un nouveau leader européen de la bio-CDMO
30 mai 2023 16h06 HE
|
EUREKARE
eureKING, premier SPAC européen de la santé dédié à la bioproduction, annonce la signature d'une option de vente pour l’acquisition potentielle de Skyepharma pour créer un nouveau leader européen de...
eureKING, the first European SPAC in healthcare dedicated to biomanufacturing, announces the signature of a put option for the potential acquisition of Skyepharma to build a new European bio-CDMO leader
30 mai 2023 16h06 HE
|
EUREKARE
Skyepharma is a France-based CDMO with over 20 years of innovation and development expertise and a renowned player in the global biopharma and consumer health industries. The company’s unique offer...
eureKING, le premier SPAC européen dans la santé dédié à la bioproduction, annonce son intention de se rapprocher de Skyepharma pour créer un nouveau leader européen de la bio-CDMO
16 mai 2023 11h45 HE
|
EUREKARE
Skyepharma, un CDMO (« Contract Development Manufacturing Organisation ») basé en France avec plus de 20 ans d'expertise en matière d'innovation et de développement, est un acteur reconnu dans les...
eureKING, the first European SPAC in healthcare dedicated to biomanufacturing, announces its intention to combine with Skyepharma to build a new European bio-CDMO leader
16 mai 2023 11h45 HE
|
EUREKARE
Skyepharma, a France-based CDMO with over 20 years of innovation and development expertise, is a renowned player in the global biopharma and consumer health industries. The company’s unique offer in...
Cell Line Development Market Size & Share | North America, Europe, & APAC Industry Forecasts 2027: Graphical Research
13 sept. 2021 06h00 HE
|
Graphical Research
Pune, India, Sept. 13, 2021 (GLOBE NEWSWIRE) -- The global cell line development market size is anticipated to grow at a significant rate during the forecast period owing to the rise in various...
Cell Line Development Market size to exceed $7.4bn by 2023: Global Market Insights Inc.
23 mai 2016 03h49 HE
|
Global Market Insights, Inc
Dover, DE, May 23, 2016 (GLOBE NEWSWIRE) -- Cell Line Development Market size is projected to reach USD 7.45 billion by 2023; as per the latest research report by Global Market Insights, Inc....